Crossmark

Insights for lncH19, miR-9, and miR-146a expression levels and their cross-talk with pro-inflammatory cytokines, copeptin, and neopterin profile in type 1 diabetic cardiomyopathy

Crossref DOI link: https://doi.org/10.1007/s11033-025-10672-3

Published Online: 2025-06-13

Published Print: 2025-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Radwan, Marwa A.

Hasona, Nabil A.

Moneim, Adel Abdel

Rabea, Alaa M.

Khalil, Rehab G. https://orcid.org/0000-0002-2501-034X
License Information

Text and Data Mining valid from 2025-06-13

Version of Record valid from 2025-06-13
More Information

Article History

Received: 14 April 2025

Accepted: 30 May 2025

First Online: 13 June 2025

Declarations

:

: This study was conducted in compliance with the Declaration of Helsinki, and the informed consent was approved by the Ethics Committee at the Faculty of Medicine, Beni-Suef University provided its approval (FMBSUREC/03102023).

: Not applicable.

: Not applicable.

: The authors declare no competing interests.

Document is current

Any future updates will be listed below